Discover your next big idea for life sciences at PACK EXPO Las Vegas
Experience a breakthrough in life sciences packaging—explore solutions from 2,300 suppliers spanning all industries, all in one place this September

FDA Approves Most Expensive Drug in History

The FDA just approved a new drug to treat a rare and deadly genetic disorder, and it costs more than $2 million.

Zolgensma / Image: PMLive
Zolgensma / Image: PMLive

A recent My Healthy Click article reported on the FDA approval of the most expensive medication in history. The drug, Zolgensma, is sold by Novartis and used to treat children under two who suffer from a rare genetic disorder called spinal muscular atrophy. The disorder only affects about 400 babies each year, but the effects are lethal. Children with the condition experience a deterioration of muscle control losing the ability to move, swallow, or breathe.

The medication is a one-time infusion that takes about an hour to administer. It costs $2.125 million, but Novartis said it would allow insurers to make annual payments of $425,000 for five years. The out-of-pocket costs for patients will obviously vary depending on their insurance plan.

FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
FDA warning letters surge - is your team prepared?
Pharmaceutical Innovations Report
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Learn More
Pharmaceutical Innovations Report